Effects of Clinacanthus siamensis leaf extract on influenza virus infection

Microbiology and Immunology

Volumn 53, Issue 2, 2009, Pages 66-74

  Wirotesangthong, Mali ^a   Nagai, Takayuki ^b   Yamada, Haruki ^b   Amnuoypol, Surattana ^a   Mungmee, Chutichot ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Anti influenza virus activity; Clinacanthus siamensis; Protective effect; Thai medicinal plant

Indexed keywords

CLINACANTHUS SIAMENSIS EXTRACT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; OSELTAMIVIR; PLANT EXTRACT; RIBAVIRIN; SIALIDASE; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CLINACANTHUS SIAMENSIS; CONTROLLED STUDY; DRUG ISOLATION; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA; INFLUENZA VIRUS A; MEDICINAL PLANT; MOUSE; NONHUMAN; PLANT LEAF; ACANTHACEAE; ANIMAL; BLOOD; BODY WEIGHT; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; ORTHOMYXOVIRUS; ORTHOMYXOVIRUS INFECTION;

CLINACANTHUS; MUS; ORTHOMYXOVIRIDAE;

ACANTHACEAE; ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; BODY WEIGHT; CELL LINE; FEMALE; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR; PLANT EXTRACTS; PLANT LEAVES; PLANTS, MEDICINAL;

EID: 64049114367     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2008.00095.x     Document Type: Article

References (27)

1. Hurt A.C., Barr I.G., Hartel G., Hampson A.W. (2004) Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir. Antiviral Res 62: 37-45.
2. Weiss E.I., Houri-Haddad Y., Greenbaum E., Hochman N., Ofek I., Zakay-Rones Z. (2005) Cranberry juice constituents affect influenza virus adhesion and infectivity. Antiviral Res 66: 9-12.
3. Nagai T., Nishibe Y., Makino Y., Tomimori T., Yamada H. (1997) Enhancement of in vivo anti-influenza virus activity of 5,7,4'-trihydroxy-8-methoxyflavone by drug delivery system using hydroxypropyl cellulose. Biol Pharm Bull 20: 1082-5.
4. Yamada H., Nagai T. (1998) In vivo anti-influenza virus activity of Kampo medicine Sho-seiryu-to through mucosal immune system. Meth Find Exp Clin Pharmacol 20: 185-92.
5. Admon D., Engelhard D., Strauss N., Goldman N., Zakay-Rones Z. (1997) Antibody response to influenza immunization in patients after heart transplantation. Vaccine 15: 1518-22.
6. Keren G., Segev S., Morag A., Zakay-Rones Z., Barzilai A., Rubin-stein E. (1988) Failure of influenza vaccination in the aged. J Med Virol 25: 85-9.
7. World Health Organization. (1999) Influenza and guidelines for national and regional planning.WHO Department of Communicable Disease Surveillance and Response. http:www.who.int/emc-docu.
8. Cox N.J., Subbarao K. (1999) Influenza. Lancet 354: 1277-82.
9. Suzuki H., Saito R.,Masuda H., Oshitani H., Sato M., Sato I. (2003) Emergence of amantadine-resistant influenza A viruses: epidemiological study. J Infect Chemother 9: 195-200.
10. Kiso M., Mitamura K., Sakai-Tagawa Y., Shiraishi K., Kawakami C., Kimura K. et al. (2004) Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364: 759-65.
11. Akanitapichat P.,Wangmaneerat A.,Wilairat P., Bastow K.F. (2006) Anti-herpes virus activity of Dunbaria bella Prain. J Ethnopharmacol 105: 64-8.
12. Sangkitporn S., Polihan K., Thawatsupa P., Bunchok M., Chawalitthumrong P. (1993) Treatment of recurrent genital herpes simplex virus infections with Clinacanthus nutans extract. Bull Dept Med Serv 18: 226-31.
13. Wirotesangthong M., Rattanakiat S. (2006) Anti-herpes simplex virus type 2 activities of some Thai medicinal plants. Thai J Pharm Sci 30: 19-27.
14. Sangkitporn S., Chaiwat S., Balachandra K., Dechotiwongse Na-Ayudhaya T., Bunchok M., Jawasu C. (1995) Treatment of herpes zoster with Clinacanthus nutans (BiPhya Yaw) extract. J Med Assoc Thai 78: 624-7.
15. Wongsatit C., Chaweewan J. (1998) Medicinal plants in Ubon Ratchathanee. Thai J Phytopharmacy 5: 28-56.
16. Reed L.J., Muench H. (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27: 493-7.
17. Nagai T., Kiyohara H., Munakata K., Shirahata T., Sunazuka T., Harigaya Y. et al. (2002) Pinellic acid from the tuber of Pinellia ternate Breitenbach as an effective oral adjuvant for nasal influenza vaccine. Int Immunopharmacol 2: 1183-93.
18. Abe Y., Hashimoto S., Horie T. (1999) Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39: 41-7.
19. Wirotesangthong M., Rattanakiat S., Katsuhiko M., Vimolmas L. (2007) Characterization of herpes simplex virus type I selected in culture for resistance to acyclovir or foscarnet. Thai J Pharm Sci 31: 36-44.
20. Kanchanapoom T., Kasai R., Yamasaki K. (2002) Iridoid glucosides from Thunbergia laurifolia. Phytochem 60: 769-71.
21. Oonsivilai R., Cheng C., Bomser J., Ferruzzi M.G., Ningsanond S. (2007) Phytochemical profiling and phase II enzyme-inducing properties of Thunbergia laurifolia Lindl. (RC) extracts. J Ethnopharmacol 114: 300-6.
22. Nawawi A., Nakamura N., Hattori M., Kurokawa M., Kimiyasu S. (1999) Inhibitory effects of Indonesian medicinal plants on the infection of herpes simplex virus type 1. Phytother Res 13: 37-41.
23. Hattori M., Nagabayashi T., Lim Y. (1995) Inhibition effects of various Ayurvedic and Panamanian medicinal plants on the infection of herpes simplex virus-1 in vitro and in vivo. Phytother Res 9: 270-6.
24. Tuntiwachwuttikul P., Pootaeng-on Y., Pansa P., Srisanpang T., TaylorW.C. (2003) Sulfur-containing compounds from Clinacanthus siamensis. Chem Pharm Bull 51(12): 1423-5.
25. Kong W.P., Hood C., Yang Z.Y., Wei C.J., Xu L., Garcia-Sastre A. et al. (2006) Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. PNAS 103(43): 15 987-91.
26. Hanson B.J., Boon A.C., Lim A.P., Webb A., Ooi E.E., Webby R.J. (2006) Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice. Respir Res 7: 126-35.
27. Burger R.A., Billingsley J.L., Huffman J.H., Bailey K.W., Kim C.U., Sidwell R.W. (2000) Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice. Immunopharmacol 47: 45-52.